| Title |
Confronting chemobrain: an in-depth look at survivors’ reports of impact on work, social networks, and health care response
|
|---|---|
| Published in |
Journal of Cancer Survivorship, September 2009
|
| DOI | 10.1007/s11764-009-0098-x |
| Pubmed ID | |
| Authors |
Nelli Boykoff, Mona Moieni, Saskia Karen Subramanian |
| Abstract |
Mild cognitive impairment following chemotherapy is one of the most commonly reported post treatment symptoms by breast cancer survivors. This deterioration in cognitive function, commonly referred to as "chemobrain" or "chemofog," was largely unacknowledged by the medical community until recent years. Although chemobrain has now become the subject of more vigorous exploration, little is known about this specific phenomenon's psychosocial impact on breast cancer survivors. This research documents in-depth the effects that cognitive impairment has on women's personal and professional lives, and our data suggest that greater attention needs to be focused on this arena of survivorship. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 369 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Japan | 2 | <1% |
| Chile | 1 | <1% |
| France | 1 | <1% |
| Brazil | 1 | <1% |
| Australia | 1 | <1% |
| Puerto Rico | 1 | <1% |
| United States | 1 | <1% |
| Unknown | 361 | 98% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 65 | 18% |
| Student > Master | 64 | 17% |
| Student > Bachelor | 56 | 15% |
| Researcher | 35 | 9% |
| Student > Doctoral Student | 31 | 8% |
| Other | 48 | 13% |
| Unknown | 70 | 19% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 82 | 22% |
| Medicine and Dentistry | 62 | 17% |
| Nursing and Health Professions | 31 | 8% |
| Neuroscience | 24 | 7% |
| Social Sciences | 18 | 5% |
| Other | 69 | 19% |
| Unknown | 83 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 August 2016.
All research outputs
#3,234,676
of 22,665,794 outputs
Outputs from Journal of Cancer Survivorship
#260
of 958 outputs
Outputs of similar age
#9,882
of 80,924 outputs
Outputs of similar age from Journal of Cancer Survivorship
#1
of 1 outputs
Altmetric has tracked 22,665,794 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 958 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.5. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 80,924 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 1 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them